We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

119 hedge funds and large institutions have $391M invested in IVERIC bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 11

267% more funds holding in top 10

Funds holding in top 10: 3 → 11 (+8)

246% more capital invested

Capital invested by funds: $113M → $391M (+$278M)

59% more funds holding

Funds holding: 75 → 119 (+44)

52% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 21

16% more call options, than puts

Call options by funds: $1.27M | Put options by funds: $1.09M

Holders
119
Holders Change
+44
Holders Change %
+58.67%
% of All Funds
2.44%
Holding in Top 10
11
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+266.67%
% of All Funds
0.23%
New
55
Increased
32
Reduced
21
Closed
11
Calls
$1.27M
Puts
$1.09M
Net Calls
+$177K
Net Calls Change
-$238K

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$29.6M
2
RI
RTW Investments
New York
+$27.5M
3
VC
Vivo Capital
California
+$24.9M
4
DM
Deerfield Management
New York
+$14.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.8M

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$8.9M
2
Deutsche Bank
Deutsche Bank
Germany
-$3.34M
3
Invesco
Invesco
Georgia
-$2.64M
4
Millennium Management
Millennium Management
New York
-$1.77M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Acuta Capital Partners
California
$3.51M +$2.29M +548,500 +395%
Morgan Stanley
27
Morgan Stanley
New York
$3.02M +$1.17M +281,609 +90%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$2.88M +$1.19M +284,630 +102%
Northern Trust
29
Northern Trust
Illinois
$2.58M +$1.81M +434,230 +600%
Goldman Sachs
30
Goldman Sachs
New York
$2.53M +$1.5M +361,040 +267%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.16M -$883K -211,981 -33%
DCM
32
DAFNA Capital Management
California
$1.82M +$1.49M +357,500 New
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.57M -$834K -200,229 -39%
ASP
34
Adams Street Partners
Illinois
$1.57M +$1.29M +308,539 New
HP
35
Harbourvest Partners
Massachusetts
$1.57M +$1.29M +308,540 New
MIOT
36
Massachusetts Institute of Technology
Massachusetts
$1.57M +$1.28M +308,139 New
PPA
37
Parametric Portfolio Associates
Washington
$1.4M +$1.14M +274,000 New
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$1.34M -$264K -63,386 -19%
Invesco
39
Invesco
Georgia
$1.28M -$2.64M -632,645 -72%
N
40
Nuveen
North Carolina
$1.09M +$893K +214,238 New
SFM
41
Sphera Funds Management
Israel
$1.02M +$319K +76,576 +62%
TOPU
42
Trustees of Princeton University
New Jersey
$874K +$714K +171,411 New
HIM
43
Hillsdale Investment Management
Ontario, Canada
$830K +$678K +162,800 New
LP
44
Lexington Partners
New York
$785K +$642K +153,977 New
Alyeska Investment Group
45
Alyeska Investment Group
Illinois
$784K +$641K +153,767 New
MIM
46
Monashee Investment Management
Massachusetts
$765K +$625K +150,000 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$739K +$514K +123,342 +570%
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$699K – – –
Two Sigma Advisers
49
Two Sigma Advisers
New York
$678K +$242K +58,000 +77%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$640K +$523K +125,490 New
1
2
3 4 5

ISEE Hedge Fund Activity: Q2 2020 in Review

119 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2020, worth a combined $391M — up 246% from $113M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new ISEE positions and 11 closed out — a net gain of 44 holders — while 32 added to existing stakes and 21 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $29.6M. The largest seller was VR Adviser, exiting entirely with an estimated $8.9M sold.

  • 119 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2020, up from 75 in Q1 2020.
  • Funds reported $391M of IVERIC bio, Inc. Common Stock stock for Q2 2020, up 246% quarter-over-quarter.
  • 55 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2020 and 11 closed out, a net change of +44 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2020 was Avoro Capital Advisors, an estimated $29.6M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2020 was VR Adviser, an estimated $8.9M sold.

Based on aggregated 13F filings for Q2 2020.